Full-Time

Machine Learning Research Scientist

Atomistic Simulation Models

Achira

Achira

11-50 employees

Atomistic drug-discovery simulation platform

Compensation Overview

$164.6k - $259k/yr

San Francisco, CA, USA + 1 more

More locations: New York, NY, USA

In Person

Category
AI & Machine Learning (1)
Required Skills
Python
Neural Networks
Pytorch
Reinforcement Learning
Requirements
  • PhD (or equivalent research experience) in computer science, statistics, applied mathematics, computational chemistry/biology, or related field.
  • Demonstrated track record in probabilistic machine learning and generative modeling (publications, impactful open-source, or deployed systems).
  • Industry experience tackling practical machine learning problems.
  • Hands-on experience with diffusion/flows/flow matching on structured or geometric data.
  • Practical experience with sequential Monte Carlo/AIS/tempering and/or advanced Markov chain Monte Carlo.
  • Proficiency in Python with PyTorch and/or JAX; strong software engineering hygiene.
  • Familiarity with biomolecular structure and data representations (graphs/3D/SMILES).
Responsibilities
  • Develop conditional molecular generators: Build conditional small-molecule generators (e.g., pocket/scaffold/pharmacophore- and property-conditioned) using generative modeling strategies such as diffusion models, normalizing flows, and flow matching with 3D- and symmetry-aware representations.
  • Develop efficient samplers: Develop sequential sampling pipelines (e.g. SMC/AIS/tempering/Boltzmann generators) that anneal from learned priors into probabilities induced by Achira’s ML potentials, maximizing ESS and reducing bias/variance.
  • Couple learning and sampling: Design learned proposal mechanisms (transport maps, score-guided moves) that adapt to stiff, multimodal landscapes and improve mixing and wall-clock efficiency.
  • Leverage nonequilibrium statistical mechanics: Where beneficial, use nonequilibrium switching protocols and work-based estimators to accelerate exploration and estimate partition-function ratios/affinity proxies.
  • Measure what matters: Define and track relevant metrics (ESS/compute, acceptance probabilities) and build reliable evaluation harnesses for fast, physics-informed feedback.
  • Experiment and engineer for reproducibility: Collaborate with our engineering team to implement robust research software in Python (PyTorch and/or JAX), with tests, CI, experiment tracking, and clear documentation.
  • Collaborate closely: Partner with computational chemistry, AI/ML, and platform teams to shape objectives (potency, selectivity, developability) and run prospective design studies.
  • Automate workflows: Use generative coding and experiment-management tools to accelerate iteration and close active-learning loops with synthetic data generation in the loop.]
  • desirable":["Experience with ML interatomic/energy potentials is a bonus","Background in SE(3)-equivariant architectures, geometric deep learning, or score matching on manifolds.","Experience with active learning / Bayesian optimization or RL-style acquisition for proposal selection.","Experience with implementing MCMC sampling approaches grounded in statistical mechanics—especially nonequilibrium approaches that utilize Crooks/Jarzynski—a plus.","Contributions to open-source scientific software; experience mentoring or leading small research efforts."]} orted to=functions.final_result 0 } to=functions.final_result 0 to=functions.final_result 0 } 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Achira develops atomistic foundation simulation models for drug discovery, combining geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced potentials and generative models. These models produce large synthetic datasets free from experimental artifacts, enabling true inverse design where researchers optimize compounds from desired properties. Achira serves pharmaceutical and biotech clients through partnerships, licensing, and collaborations, differentiating itself by integrating physics-based simulations with data-driven learning to mitigate data scarcity and high costs. The company's goal is to accelerate and make drug discovery more reliable by enabling inverse design that reduces time and expenses in identifying promising compounds.

Company Size

11-50

Company Stage

Seed

Total Funding

$33M

Headquarters

New York City, New York

Founded

2024

Simplify Jobs

Simplify's Take

What believers are saying

  • $33M funding from Dimension, NVIDIA, Amplify, and Compound enables pharma partnerships.
  • NVIDIA's NVentures provides GPU hardware optimized for molecular dynamics simulations.
  • Scalable high-fidelity synthetic datasets accelerate inverse design in drug discovery.

What critics are saying

  • Schrödinger outperforms Achira in protein-ligand predictions, capturing 40% more candidates.
  • NVIDIA's CUDA-Q toolkit lets competitors replicate physics-ML integration without fees.
  • FDA's 2026 mandate requires 10x empirical data, blocking Achira's synthetic models.

What makes Achira unique

  • Achira integrates geometric deep learning, physics, quantum chemistry, and statistical mechanics into simulation models.
  • Achira generates large synthetic datasets free of experimental artifacts for inverse drug design.
  • Founders John Chodera, Theofanis Karaletsos, and Zavain Dar expertize computational biology and machine learning.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Achira who can refer or advise you

Benefits

Remote Work Options

Hybrid Work Options

Flexible Work Hours

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

PTO/vacation

Paid Vacation

Paid Holidays

Unlimited Paid Time Off

401(k) Retirement Plan

Stock Options

Company Equity

Wellness Program

Mental Health Support

Gym Membership

Conference Attendance Budget

Professional Development Budget

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Confluence

Company News

Ethnikos Kirikas & The National Herald Inc.
Apr 10th, 2025
Achira AI Secures $33M in Funding

Greek startup Achira AI has secured $33 million in funding from top investors, including Dimension, Nvidia, Amplify, and Compound. Achira aims to revolutionize AI-enabled drug development by integrating geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced simulation models. This approach seeks to overcome limitations in current biomolecular simulations and machine learning models, accelerating the discovery of new molecules and treatments.

Endpoints News
Feb 21st, 2025
Nvidia-backed Achira debuts, blending AI and physics to model molecules

As he was testing new antivirals to halt a future pandemic, John Chodera encountered an unlikely set of new problems that ultimately helped lead to his new job. The computational ...